Table 2.
Conditiona | Age, sexb | HFE genotype | Thyroid-stimulating hormone (TSH), mIU/L | Free thyroxine (T4), ng/dL | Serum ferritin, ng/mLc |
---|---|---|---|---|---|
Hypothyroidism | 20s F | wt/wt | 291 | 0.16 | 23 |
Hypothyroidism | 50s F | wt/wt | 88.9 | 0.36 | 90 |
Hypothyroidism | 50s F | wt/wt | 19.4 | 0.69 | 27 |
Hyperthyroidism | 50s M | C282Y/C282Y | 0.014 | 2.04 | 24 |
Hyperthyroidism | 20s F | C282Y/C282Y | 0.009 | 1.98 | 124 |
Hyperthyroidism | 70s M | C282Y/C282Y | 0.007 | 4.59 | 1,462 |
Hyperthyroidism | 40s M | wt/wt | 0.064 | 2.11 | 144 |
Hyperthyroidismd | 50s M | wt/wt | 0.054 | 2.07 | 230 |
Hyperthyroidism | 80s M | wt/wt | 0.015 | 2.35 | 199 |
Hyperthyroidismd | 40s F | wt/wt | 0.011 | 2.73 | 124 |
We defined hypothyroidism as the concurrence of TSH >5.00 mIU/L and free T4 <0.70 ng/dL, and hyperthyroidism as the concurrence of TSH <0.400 mIU/L and free T4 >1.85 ng/dL. These measurements were performed at the time of post-initial screening examination. For display of TSH values, we used three significant figures.
It is the privacy policy of the HEIRS Study to display the age of individual subjects by decade.
The mean serum ferritin level was lower in participants with hypothyroidism than in those with hyperthyroidism (38 ng/mL vs. 167 ng/mL, respectively; p = 0.0446).
These participants reported that they took thyroid supplements.